| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |